Enterprise Value

39.46B

Cash

397.4M

Avg Qtr Burn

N/A

Short % of Float

3.26%

Insider Ownership

0.93%

Institutional Own.

92.61%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date